Eupraxia Pharmaceuticals is trading 11.83% up now at $7.09, with broader healthcare strength appearing to drive the move.
- No clear company-specific announcement was identified on September 2, 2026.
- The latest releases were August 13 clinical-response data and August 11 second-quarter results, making them stale catalysts rather than new-day explanations.
- Healthcare is gaining 1.37%, supported by strong medical-device earnings.